Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-43,500
Closed -$471K 2657
2023
Q4
$471K Sell
43,500
-42,000
-49% -$402K ﹤0.01% 1597
2023
Q3
$843K Buy
85,500
+43,500
+104% +$453K ﹤0.01% 1378
2023
Q2
$419K Hold
42,000
﹤0.01% 1295
2023
Q1
$404K Hold
42,000
﹤0.01% 1285
2022
Q4
$467K Buy
+42,000
New +$439K ﹤0.01% 1158

Other funds holding VTRS

Steven Cohen's VTRS Position: Q2 2026 in Review

Steven Cohen reduced its Viatris (VTRS) stake by 68% in Q2 2026, selling an estimated $18.8M and leaving 563,129 shares worth $8.94M. The position accounts for 0.01% of the portfolio, ranked #1351.

Steven Cohen first reported a position in VTRS in Q2 2014 and has held it in 33 quarters since. The position peaked at $170M in Q4 2017. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Steven Cohen held 563,129 shares of Viatris worth $8.94M as of Q2 2026.
  • Steven Cohen sold 1,214,052 Viatris shares in Q2 2026, an estimated $18.8M.
  • Viatris made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1351 holding.
  • Steven Cohen first reported a position in Viatris in Q2 2014 and has held it in 33 quarters since.
  • Steven Cohen's Viatris position peaked at $170M in Q4 2017.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.